Broadened Treatment Options for Primary Biliary Cholangitis Leave Open Questions
Spotlight On > > AASLD: PBC-- Two brand-new drugs provide pledge after obeticholic acid loses out on complete approval
by Tara Haelle, Contributing Writer, MedPage Today November 30, 2024
The approval of ursodeoxycholic acid (UDCA) for main biliary cholangitis (PBC) in 1997 marked a critical pivotal moment in management of the condition, considerably minimizing the danger of liver transplant and death. UDCA's arrival was not a remedy for all clients with PBC.
As much as 40% of clients with PBC will not adequately react to UDCA, David N. Assis, MD, of Yale Liver Clinics and Yale New Haven Hospital in New Hav...